{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:22:18Z","timestamp":1771953738321,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1124\/jpet.115.225375","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T01:50:21Z","timestamp":1446083421000},"page":"516-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Early Administration of Carvedilol Protected against Doxorubicin-Induced Cardiomyopathy"],"prefix":"10.1016","volume":"355","author":[{"given":"Yung-Lung","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Ying","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Tan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien-Hung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Yi","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Hsun","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheuk-Kwan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-I","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan-Yen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiunn-Jye","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hon-Kan","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.115.225375_bib1","first-page":"1789","article-title":"Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis","volume":"60","author":"Arola","year":"2000","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.115.225375_bib2","doi-asserted-by":"crossref","first-page":"430549","DOI":"10.5402\/2011\/430549","article-title":"Carvedilol-afforded protection against daunorubicin-induced cardiomyopathic rats in vivo: effects on cardiac fibrosis and hypertrophy","volume":"2011","author":"Arozal","year":"2011","journal-title":"ISRN Pharmacol"},{"key":"10.1124\/jpet.115.225375_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tox.2010.05.003","article-title":"Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats","volume":"274","author":"Arozal","year":"2010","journal-title":"Toxicology"},{"key":"10.1124\/jpet.115.225375_bib4","first-page":"505","article-title":"Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity","volume":"11","author":"Bai","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1124\/jpet.115.225375_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-80-2-249","article-title":"Adriamycin. A new anticancer drug with significant clinical activity","volume":"80","author":"Blum","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.115.225375_bib6","first-page":"439","article-title":"Melatonin augments apoptotic adipose-derived mesenchymal stem cell treatment against sepsis-induced acute lung injury","volume":"6","author":"Chen","year":"2014","journal-title":"Am J Transl Res"},{"key":"10.1124\/jpet.115.225375_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jpi.12164","article-title":"Melatonin treatment further improves adipose-derived mesenchymal stem cell therapy for acute interstitial cystitis in rat","volume":"57","author":"Chen","year":"2014","journal-title":"J Pineal Res"},{"key":"10.1124\/jpet.115.225375_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12967-014-0357-0","article-title":"Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats","volume":"12","author":"Chua","year":"2014","journal-title":"J Transl Med"},{"key":"10.1124\/jpet.115.225375_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5603\/CJ.a2013.0150","article-title":"Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: a prospective randomized controlled study with six-month follow-up","volume":"21","author":"Elitok","year":"2014","journal-title":"Cardiol J"},{"key":"10.1124\/jpet.115.225375_bib10","doi-asserted-by":"crossref","first-page":"22800","DOI":"10.1074\/jbc.272.36.22800","article-title":"A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes","volume":"272","author":"Jeyaseelan","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.115.225375_bib11","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","article-title":"Protective effects of carvedilol against anthracycline-induced cardiomyopathy","volume":"48","author":"Kalay","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.115.225375_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1015976430790","article-title":"Doxorubicin-induced apoptosis: implications in cardiotoxicity","volume":"234\u2013235","author":"Kalyanaraman","year":"2002","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/jpet.115.225375_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0163-7258(90)90088-J","article-title":"Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity","volume":"47","author":"Keizer","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.115.225375_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0022-2828(89)90782-7","article-title":"Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles","volume":"21","author":"Kim","year":"1989","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.115.225375_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijcard.2010.03.007","article-title":"Autologous bone marrow cell implantation attenuates left ventricular remodeling and improves heart function in porcine myocardial infarction: an echocardiographic, six-month angiographic, and molecular-cellular study","volume":"150","author":"Leu","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1124\/jpet.115.225375_bib16","first-page":"711","article-title":"Assessment of left ventricular systolic dysfunction by tissue Doppler imaging to detect subclinical cardiomyopathy early after anthracycline therapy","volume":"55","author":"Lotrionte","year":"2007","journal-title":"Minerva Cardioangiol"},{"key":"10.1124\/jpet.115.225375_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine","volume":"64","author":"Maron","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.115.225375_bib18","doi-asserted-by":"crossref","first-page":"H1871","DOI":"10.1152\/ajpheart.00663.2011","article-title":"Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy","volume":"302","author":"Masuda","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"10.1124\/jpet.115.225375_bib40","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0024-3205(99)00362-8","article-title":"Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats","volume":"65","author":"Matsui","year":"1999","journal-title":"Life Sci."},{"key":"10.1124\/jpet.115.225375_bib19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/HYPERTENSIONAHA.109.141903","article-title":"Attenuation of doxorubicin-induced cardiomyopathy by endothelin-converting enzyme-1 ablation through prevention of mitochondrial biogenesis impairment","volume":"55","author":"Miyagawa","year":"2010","journal-title":"Hypertension"},{"key":"10.1124\/jpet.115.225375_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pcad.2014.03.003","article-title":"Myocardial mechanics in cardiomyopathies","volume":"57","author":"Modesto","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1124\/jpet.115.225375_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.CIR.103.4.555","article-title":"Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase\/Akt phosphorylation and Bcl-xL\/caspase-3 interaction","volume":"103","author":"Negoro","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/jpet.115.225375_bib22","first-page":"6602","article-title":"Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1","volume":"63","author":"Olson","year":"2003","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.115.225375_bib23","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1096\/fasebj.4.13.2210154","article-title":"Doxorubicin cardiotoxicity: analysis of prevailing hypotheses","volume":"4","author":"Olson","year":"1990","journal-title":"FASEB J"},{"key":"10.1124\/jpet.115.225375_bib24","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/jpet.115.225375_bib25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2174\/138161282104141204142436","article-title":"Mechanisms and medical management of exercise intolerance in hypertrophic cardiomyopathy","volume":"21","author":"Patel","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.115.225375_bib26","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2174\/138161211796904812","article-title":"Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol","volume":"17","author":"Pereira","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.115.225375_bib27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.echo.2012.04.007","article-title":"Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction","volume":"25","author":"Poterucha","year":"2012","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1124\/jpet.115.225375_bib28","first-page":"4766","article-title":"Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity","volume":"48","author":"Rajagopalan","year":"1988","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.115.225375_bib29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrcardio.2009.130","article-title":"Vascular dysfunction in idiopathic dilated cardiomyopathy","volume":"6","author":"Roura","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1124\/jpet.115.225375_bib30","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","article-title":"Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991","volume":"98","author":"Senni","year":"1998","journal-title":"Circulation"},{"key":"10.1124\/jpet.115.225375_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00059-011-3470-3","article-title":"Mechanisms and management of doxorubicin cardiotoxicity","volume":"36","author":"Shi","year":"2011","journal-title":"Herz"},{"key":"10.1124\/jpet.115.225375_bib32","doi-asserted-by":"crossref","first-page":"316214","DOI":"10.1155\/2014\/316214","article-title":"Reducing TRPC1 expression through liposome-mediated siRNA delivery markedly attenuates hypoxia-induced pulmonary arterial hypertension in a murine model","volume":"2014","author":"Sun","year":"2014","journal-title":"Stem Cells Int"},{"key":"10.1124\/jpet.115.225375_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1536\/ihj.50.191","article-title":"Impact of hyperglycemic control on left ventricular myocardium. A molecular and cellular basic study in a diabetic rat model","volume":"50","author":"Sung","year":"2009","journal-title":"Int Heart J"},{"key":"10.1124\/jpet.115.225375_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/10715769800300421","article-title":"Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism","volume":"29","author":"Tadolini","year":"1998","journal-title":"Free Radic Res"},{"key":"10.1124\/jpet.115.225375_bib35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.115.225375_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/faat.1997.2320","article-title":"Mitochondria-mediated cell injury. Symposium overview","volume":"38","author":"Wallace","year":"1997","journal-title":"Fundam Appl Toxicol"},{"key":"10.1124\/jpet.115.225375_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1253\/circj.70.163","article-title":"N-terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"70","author":"Wu","year":"2006","journal-title":"Circ J"},{"key":"10.1124\/jpet.115.225375_bib38","doi-asserted-by":"crossref","first-page":"40113","DOI":"10.1074\/jbc.M004108200","article-title":"Expression of constitutively active phosphatidylinositol 3-kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells","volume":"275","author":"Wu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.115.225375_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1749-6632.1994.tb21808.x","article-title":"Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotection","volume":"738","author":"Yue","year":"1994","journal-title":"Ann N Y Acad Sci"}],"updated-by":[{"DOI":"10.1124\/jpet.115.225375err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524191781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524191781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.115.225375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:37:42Z","timestamp":1739993862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524191781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0022356524191781"],"URL":"https:\/\/doi.org\/10.1124\/jpet.115.225375","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/jpet.115.225375err","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Administration of Carvedilol Protected against Doxorubicin-Induced Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.115.225375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}